Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9913298 | 1.00 | TDP1 (0.47) | TDP1 | |
| SCHEMBL276661 | 0.85 | TDP1 (0.33) | TDP1 | |
| SCHEMBL13075675 | 0.73 | GAA (0.32) | TDP1 | |
| SCHEMBL7961098 | 0.73 | CYP3A4 (0.34) | — | |
| SCHEMBL21843930 | 0.73 | TDP1 (0.41) | TDP1 | |
| SCHEMBL18467862 | 0.73 | — | — | |
| SCHEMBL13937735 | 0.73 | TDP1 (0.41) | TDP1 | |
| SCHEMBL21448478 | 0.73 | TDP1 (0.41) | TDP1 | |
| SCHEMBL13080667 | 0.71 | TDP1 (0.47) | TDP1 | |
| SCHEMBL16746700 | 0.71 | TDP1 (0.47) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399538-A1 | POLYUREA COPOLYMER COATING COMPOSITIONS AND METHODS | INNOVATIVE SURFACE TECHNOLOGIES, INC. | 2023-12-14 | — | — | US | disclosed |
| US-11781035-B2 | Polyurea copolymer coating compositions and methods | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230241287-A1 | SILICONE POLYUREA BLOCK COPOLYMER COATING COMPOSITIONS AND METHODS | INNOVATIVE SURFACE TECH INC (US) | 2023-08-03 | — | — | US | disclosed |
| US-20230241287-A1 | SILICONE POLYUREA BLOCK COPOLYMER COATING COMPOSITIONS AND METHODS | INNOVATIVE SURFACE TECH INC (US) | 2023-08-03 | — | — | US | disclosed |
| US-11672884-B2 | Silicone polyurea block copolymer coating compositions and methods | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-11672884-B2 | Silicone polyurea block copolymer coating compositions and methods | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-11247179-B2 | Method of preparing membranes | APPLIED BIOMIMETIC A/S (DK) | 2022-02-15 | — | — | US | disclosed |
| US-20200405909-A1 | SILICONE POLYUREA BLOCK COPOLYMER COATING COMPOSITIONS AND METHODS | INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) | 2020-12-31 | — | — | US | disclosed |
| US-10544358-B2 | Coated and cured proppants | PREFERRED TECHNOLOGY, LLC (US) | 2020-01-28 | — | — | US | disclosed |
| US-10208242-B2 | Proppant with polyurea-type coating | PREFERRED TECHNOLOGY, LLC (US) | 2019-02-19 | — | — | US | disclosed |
| US-7329663-B2 | Substituted-triazolopyrimidines as anticancer agents | WYETH (US) | 2008-02-12 | — | — | US | disclosed |
| US-20070232549-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION | 2007-10-04 | — | — | US | disclosed |
| US-7244721-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |
| US-20070142301-A1 | Novel inhibitors of Hepatitis C virus NS3 protease | MERCK SHARP & DOHME CORP. | 2007-06-21 | — | — | US | disclosed |
| US-20070093430-A1 | Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus | MERCK SHARP & DOHME CORP. | 2007-04-26 | — | — | US | disclosed |
| US-7205330-B2 | Inhibitors of hepatitis C virus NS3 protease | SCHERING CORPORATION (US) | 2007-04-17 | — | — | US | disclosed |
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2007-02-22 | — | — | US | disclosed |
| US-20070032433-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION CORVAS INTERNATIONAL, LTD. | 2007-02-08 | — | — | US | disclosed |
| US-7173057-B2 | Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus | SCHERING CORPORATION (US) | 2007-02-06 | — | — | US | disclosed |
| WO-2005030796-A1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE | SCHERING CORPORATION (US) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232549-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | HPN, TMPRSS15, VIP | TDP1 3248/4885 |
| US-20070142301-A1 | Novel inhibitors of Hepatitis C virus NS3 protease | HAVCR2, RNASE1, SERPINB1 | TDP1 2686/4885 |
| US-20070093430-A1 | Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus | PREP, PRSS1, P4HB | TDP1 3327/4885 |
| US-20070032433-A1 | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus | HPN, TMPRSS15, VIP | TDP1 3248/4885 |
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | PRSS1, PRSS3, HPN | TDP1 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.